News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–42
Matches
42
Sources here
2
Companies here
1
Search results Stored financial headlines

Active search

42 matching headlines

Ticker or company: CTMXMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Earnings Main company 🇺🇸 United States

CytomX Therapeutics Inc (CTMX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for CytomX Therapeutics Inc (CTMX). It indicates that the company has not yet disclosed relevant data for fiscal years, quarters, or by business segment. The available regional revenue data shows United States contributing $76.20 million, but …

CTMX main company
Sharemaestro market context Price below Trend Line 52 weeks +58.5% · Next-week setup negative 43.7% CTMX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

CytomX Therapeutics Inc (CTMX) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides dividend and stock split information for CytomX Therapeutics Inc (CTMX). It states that the company has distributed $0.00 in dividends over the past five years, indicating no recent dividend payouts. The page also presents current stock data, including its market capitalization, …

CTMX main company
Sharemaestro market context Price below Trend Line 52 weeks +58.5% · Next-week setup negative 43.7% CTMX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

CTMX|CytomX Therapeutics Inc|Price:3.240|Chg%:-0.090

CytomX Therapeutics Inc. (CTMX) is a clinical-stage oncology biopharmaceutical company specializing in conditionally activated, masked biologics through its PROBODY therapeutic platform. The company's pipeline includes therapeutic candidates like ADCs, T-cell engagers, and immune modulators such as CX-2051, CX-904, and CX-801. The article provides detailed …

CTMX main company
Sharemaestro market context Price below Trend Line 52 weeks +58.5% · Next-week setup negative 43.7% CTMX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

TradingKey

This article provides a detailed income statement for CytomX Therapeutics Inc (CTMX) from FY2014Q1 to FY2026Q1, highlighting various financial metrics such as total revenue, operating expenses, research & development expenses, and net income. It also includes frequently asked questions about interpreting income statements on …

CTMX main company
Sharemaestro market context Price below Trend Line 52 weeks +58.5% · Next-week setup negative 43.7% CTMX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

CytomX Therapeutics Inc (CTMX) Institutional Confidence

CytomX Therapeutics Inc (CTMX) holds an institutional shareholding score of 7.00, ranking 80th in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 78.87%, reflecting a 19.41% decrease quarter-over-quarter. Bill Nygren | OAKMX is the largest institutional shareholder, holding 9.71 million shares.

CTMX main company
Sharemaestro market context Price below Trend Line 52 weeks +58.5% · Next-week setup negative 43.7% CTMX stored weekly price path from 22 Aug 2025 to 14 Aug 2026
FinancialContent Earnings Main company 🇺🇸 United States

CytomX Therapeutics, Inc. - Common Stock (NQ: CTMX)

This article compiles recent news headlines regarding CytomX Therapeutics, Inc. (CTMX), detailing earnings reports, clinical trial data, stock performance, and analyst perspectives from various financial news sources. Key events include Q4 2025 and Q1 2026 earnings transcripts, positive Phase 1 colorectal cancer data causing …

CTMX main company
Sharemaestro market context Price below Trend Line 52 weeks +58.5% · Next-week setup negative 43.7% CTMX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context